EGMN -- Daily infusion of an investigational drug known as TZP-101, a ghrelin agonist, for a period of 4 days decreased vomiting in a small group of patients with severe diabetic gastroparesis, reported Dr. John M. Wo, who presented the findings at Neurogastroenterology and Motility 2010.
